1702-1703 / 2351
Xerostomia
d l
d d
h
(
)
Intensity mo u ate ra iation t erapy IMRT
- PASSPORT phase III trial compared IMRT with to conventional RT
- n=94
IMRT
Conventional
Grade 2 xerostomia at 12 months
37%
74%
G d 2
i
24 h
29%
83%
p< 0.05
ra e xerostom a at mont s
- No difference in terms of PFS, OS, and other late toxicities
Nutting et al. Lancet Oncol 2011